These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection. Perkins JD; Nelson DL; Rakela J; Grambsch PM; Krom RA Transplant Proc; 1989 Feb; 21(1 Pt 2):2275-6. PubMed ID: 2540568 [No Abstract] [Full Text] [Related]
6. The assay of soluble IL-2R receptor levels in graft microenvironment can be helpful in differential diagnosis of transplant dysfunction. Yussim A; Shapira Z; Shohat B; Shmueli D; Zingerman B; Livne E; Klein T Transplant Proc; 1991 Feb; 23(1 Pt 1):260-2. PubMed ID: 1990528 [No Abstract] [Full Text] [Related]
7. Activation markers in late rejection of kidney allografts: fine needle aspiration biopsy analysis. Gonzalez-Posada JM; Garcia Castro C; Torres A; Lorenzo V; Losada M; Hernandez D; Maceira B; Salido E Transplant Proc; 1992 Feb; 24(1):65-6. PubMed ID: 1539347 [No Abstract] [Full Text] [Related]
8. Evaluation of serum immunological parameters in acute renal allograft rejection. Yang J; Li XW; Zheng FL; Bi ZQ Transplant Proc; 1996 Jun; 28(3):1443-4. PubMed ID: 8658732 [No Abstract] [Full Text] [Related]
9. Chronic renal allograft rejection can be predicted by the surface area under the serum creatinine versus time curve. Yilmaz S; Kallio E; Yilmaz A; Häyry P Transplant Proc; 1995 Feb; 27(1):927. PubMed ID: 7879233 [No Abstract] [Full Text] [Related]
10. Serial monitoring shows plasma protein C and free protein S levels are decreased during human acute renal allograft rejection. Tsuchida A; Thomson NM; Salem HH; Atkins RC; Hancock WW Transplant Proc; 1990 Oct; 22(5):2134-6. PubMed ID: 2145671 [No Abstract] [Full Text] [Related]
12. Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients. Noronha IL; Daniel V; Rambausek M; Waldherr R; Opelz G Transplant Proc; 1990 Aug; 22(4):1859-60. PubMed ID: 2117814 [No Abstract] [Full Text] [Related]
13. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology. Dittmer R; Harfmann P; Tenschert W; Arndt R; Busch B Transplant Proc; 1990 Oct; 22(5):2284-5. PubMed ID: 2219370 [No Abstract] [Full Text] [Related]
14. Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection. Grewal HP; Kotb M; Salem A; el Din AB; Novak K; Martin J; Gaber LW; Gaber AO Transplant Proc; 1993 Feb; 25(1 Pt 1):132-5. PubMed ID: 7679807 [No Abstract] [Full Text] [Related]
15. Urine sediment cytology in the management of renal allograft recipients. Madras PN; Simpson MA; Cornaby AJ; Dempsey RA; Clowes GH; Monaco AP Transplant Proc; 1989 Feb; 21(1 Pt 2):1842-3. PubMed ID: 2652599 [No Abstract] [Full Text] [Related]
16. Association between serum soluble CD30 and serum creatinine before and after renal transplantation. López-Hoyos M; San Segundo D; Benito MJ; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Gómez-Alamillo C; Benito A; Arias M Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142 [TBL] [Abstract][Full Text] [Related]
19. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. Andersen CB; Ladefoged SD; Larsen S APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171 [TBL] [Abstract][Full Text] [Related]
20. Critical analysis of rejection markers sIL-2R, urinary amylase, and lipase in whole-organ pancreas transplantation with exocrine bladder drainage. Abendroth D; Capalbo M; Illner WD; Landgraf R; Land W Transplant Proc; 1992 Jun; 24(3):786-7. PubMed ID: 1376524 [No Abstract] [Full Text] [Related] [Next] [New Search]